Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06) Meeting Abstract


Authors: Lambertini, M.; Campbell, C.; Bines, J.; Korde, L.; Izquierdo Delso, M. A.; Fumagalli, D.; Pritchard, K.; Wolff, A.; Jackisch, C.; Lang, I.; Untch, M.; Smith, I.; Boyle, F. M.; Xu, B.; Barrios, C. H.; Baselga, J.; Moreno-Aspitia, A.; Piccart, M.; Gelber, R.; De Azambuja, E.
Abstract Title: Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)
Meeting Title: 42nd ESMO Congress (ESMO 2017)
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 5
Meeting Dates: 2017 Sep 8-12
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-09-01
Start Page: mdx362.009
Language: English
ACCESSION: WOS:000411324000086
PROVIDER: wos
DOI: 10.1093/annonc/mdx362.009
Notes: Meeting Abstract: 158PD -- Appears on page 47 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga